Science
Mechanism of Action
Propagermanium (PG) functions as a targeted inhibitor of the C-C chemokine receptor type 2 (CCR2). This inhibition effectively blocks the activation and chemotaxis of monocytes and macrophages that are dependent on MCP-1, thereby conferring its anti-inflammatory effects within biological systems.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Propagermanium exhibits remarkable stability across a wide pH spectrum, specifically from pH 2 to 12. It maintains its structural integrity without decomposition even at elevated temperatures, such as 110°C for 5 minutes, particularly at a neutral pH of 7.4.
Safety
Safety Profile
Propagermanium has received approval as an oral pharmaceutical agent for chronic hepatitis B in Japan. However, its safety specifically for cosmetic topical applications has not been assessed by key regulatory bodies such as the CIR or SCCS. It is important to note that while not directly attributed to propagermanium in cosmetic use, inorganic germanium compounds have been associated with severe organ toxicity, including acute renal failure. This broader context surrounding germanium compounds warrants caution and thorough investigation for topical cosmetic formulations.
Your Skin
Skin Compatibility
Our Assessment
Verdict
While Propagermanium demonstrates a promising anti-inflammatory mechanism and excellent formulation stability, the complete lack of independent safety reviews for cosmetic use, coupled with toxicity concerns related to other germanium compounds, makes its inclusion in precision skincare questionable without further robust data.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources